ORIGIN Trial (Background, Results)

ORIGIN — the longest and most extensive study on Lantus® use in patients with cardiovascular risk with diabetes mellitus (DM) type 2 in the early stages, as well as prediabetes, in which insulin therapy is not indicated now. ORIGIN trial was initiated to investigate the efficacy of therapy with insu...

Full description

Bibliographic Details
Main Authors: M.D. Tronko, V.V. Poltorak, LK Sokolova
Format: Article
Language:English
Published: Publishing House Zaslavsky 2013-02-01
Series:Mìžnarodnij Endokrinologìčnij Žurnal
Online Access:http://iej.zaslavsky.com.ua/article/view/84046